GKIM
CSTL icon

GW&K Investment Management’s Castle Biosciences CSTL Stock Holding History

GW&K Investment Management’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-15
Closed – – 929
2023
Q4 		$0 Sell
15
-493,967
-100% -$8.69M ﹤0.01% 932
2023
Q3 		$8.34M Buy
493,982
+5,237
+1% +$91.6K 0.08% 248
2023
Q2 		$6.71M Sell
488,745
-6,036
-1% -$122K 0.06% 254
2023
Q1 		$11.2M Buy
494,781
+15,122
+3% +$369K 0.11% 209
2022
Q4 		$11.3M Sell
479,659
-24,404
-5% -$566K 0.11% 206
2022
Q3 		$13.1M Sell
504,063
-12,234
-2% -$343K 0.15% 191
2022
Q2 		$11.3M Sell
516,297
-94,525
-15% -$2.2M 0.12% 202
2022
Q1 		$27.4M Buy
610,822
+530
+0.1% +$21.9K 0.24% 168
2021
Q4 		$26.2M Buy
610,292
+189,918
+45% +$9.92M 0.22% 173
2021
Q3 		$28M Sell
420,374
-2,393
-0.6% -$168K 0.25% 162
2021
Q2 		$31M Buy
422,767
+740
+0.2% +$48.9K 0.27% 161
2021
Q1 		$28.9M Sell
422,027
-30,364
-7% -$2.28M 0.27% 163
2020
Q4 		$30.4M Buy
452,391
+352,568
+353% +$19.1M 0.32% 146
2020
Q3 		$5.14M Buy
99,823
+13,020
+15% +$579K 0.07% 239
2020
Q2 		$3.27M Buy
+86,803
New +$2.97M 0.05% 259

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

GW&K Investment Management's CSTL Position: Q1 2024 in Review

GW&K Investment Management sold out of Castle Biosciences (CSTL) in Q1 2024, closing a stake of 15 shares.

GW&K Investment Management first reported a position in CSTL in Q2 2020 and held it in 15 quarters. The position peaked at $31M in Q2 2021. 151 funds tracked by Wall St. Rank hold CSTL as of Q1 2024.

  • GW&K Investment Management reported no remaining Castle Biosciences position as of Q1 2024 after selling out during the quarter.
  • GW&K Investment Management sold 15 Castle Biosciences shares in Q1 2024.
  • GW&K Investment Management first reported a position in Castle Biosciences in Q2 2020 and held it in 15 quarters.
  • GW&K Investment Management's Castle Biosciences position peaked at $31M in Q2 2021.
  • 151 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2024.

Based on GW&K Investment Management's 13F filing for Q1 2024, filed 8 May 2024.